Leap Therapeutics(LPTX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Leap Therapeutics Reports Second Quarter 2024 Financial Results Cambridge, MA – August 12, 2024 – Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended June 30, 2024. Leap Highlights: · Overall response rate (ORR) increases to 33% across all evaluable patients and 38% across evaluable patients with left-sided CRC in updated data from Part A of the Phase 2 DeFia ...